The Effects of Bromelain Supplement in Patients With Ulcerative Colitis

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 20, 2024

Primary Completion Date

July 20, 2024

Study Completion Date

August 10, 2024

Conditions

Ulcerative ColitisPrimary Sclerosing Cholangitis

Interventions

DIETARY_SUPPLEMENT

Bromlein

1500 mg/day

OTHER

Placebo

Placebo (1500 mg/day)

Trial Locations (1)

RECRUITING

Azita Hekmatdoost, Tehran

All Listed Sponsors

lead

National Nutrition and Food Technology Institute

OTHER